Synflix Pharmaceutical Private Limited, a active private limited company, was established on 15 February 2018 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U74999TN2018PTC120841. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.50 M.
Its leadership includes Kannan Sudha (Director), Arunachalam Lakshmi (Director). Past directors included Ramakrishnan Chockalingam, Subramanian Venkataraman, Muthulakshmi Ramakrishnan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 99, Sidco Industrial Estate Vichoor, Chennai, Tamil Nadu, 600103.
U74999TN2018PTC120841
120841
15 February 2018
₹5.00 M
₹4.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Synflix Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannan Sudha | Director | 15 Feb 2018 | Current |
| Arunachalam Lakshmi | Director | 15 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jun 2020 | Past |
| Pramod Abcsdd | Director | 30 Jun 2020 | Past |
| Pramod Abcsdd | Director | 26 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synflix Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.69% decrease. The company also saw a substantial improvement in profitability, with a 980.46% increase in profit. The company's net worth Soared by an impressive increase of 72.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Synflix Pharmaceutical had a promoter holding of 77.78% and a public holding of 22.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synflix Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synflix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synflix Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Synflix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Synflix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Kannan Sudha was appointed as a Director was appointed as a Director on 15 Feb 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
Progress on Arunachalam Lakshmi was appointed as a Director was appointed as a Director on 15 Feb 2018 & has been associated with this company since 7 years 9 months . was documented.
Synflix Pharmaceutical Private Limited was registered on 15 Feb 2018 with Roc Chennai & aged 7 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Synflix Pharmaceutical Private Limited is U74999TN2018PTC120841.
Synflix Pharmaceutical Private Limited is headquartered at Plot No. 99, Sidco Industrial Estate Vichoor, Chennai, Tamil Nadu, 600103.
Synflix Pharmaceutical Private Limited was incorporated on 15 February 2018.
The current directors of Synflix Pharmaceutical Private Limited are
The primary industry of Synflix Pharmaceutical Private Limited is Manufacturing.
Synflix Pharmaceutical Private Limited is unlisted.
The authorized capital of Synflix Pharmaceutical Private Limited is ₹5.00 M, and the paid-up capital is ₹4.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX